The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Dacarbazine medac 500 mg, powder for solution for infusion

medac Gesellschaft für klinische Spezialpräparate mbHPA0623/003/003

Main Information

Trade NameDacarbazine medac 500 mg, powder for solution for infusion
Active SubstancesDacarbazine
Dosage FormPowder for solution for infusion
Licence Holdermedac Gesellschaft für klinische Spezialpräparate mbH
Licence NumberPA0623/003/003

Group Information

ATC CodeL01AX Other alkylating agents
L01AX04 dacarbazine


License statusAuthorised
Licence Issued14/11/1997
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back